D'Alo', Francesco
 Distribuzione geografica
Continente #
NA - Nord America 5.918
EU - Europa 4.909
AS - Asia 3.262
SA - Sud America 569
OC - Oceania 171
AF - Africa 117
Continente sconosciuto - Info sul continente non disponibili 3
Totale 14.949
Nazione #
US - Stati Uniti d'America 5.699
DE - Germania 1.723
SG - Singapore 1.322
CN - Cina 1.171
SE - Svezia 678
IT - Italia 654
BR - Brasile 467
GB - Regno Unito 300
UA - Ucraina 294
PL - Polonia 261
FR - Francia 253
IN - India 165
FI - Finlandia 163
IE - Irlanda 156
AU - Australia 149
CA - Canada 145
VN - Vietnam 113
ID - Indonesia 106
RU - Federazione Russa 73
TR - Turchia 70
NL - Olanda 55
MX - Messico 44
JP - Giappone 39
HK - Hong Kong 38
AT - Austria 37
ES - Italia 35
AR - Argentina 31
BD - Bangladesh 28
BE - Belgio 26
IR - Iran 26
CH - Svizzera 25
CI - Costa d'Avorio 23
IQ - Iraq 23
KR - Corea 23
RO - Romania 23
ZA - Sudafrica 23
NZ - Nuova Zelanda 21
CZ - Repubblica Ceca 18
IL - Israele 16
CO - Colombia 15
EG - Egitto 15
GR - Grecia 15
HU - Ungheria 15
PK - Pakistan 15
AE - Emirati Arabi Uniti 13
DZ - Algeria 13
EC - Ecuador 12
LT - Lituania 12
MA - Marocco 12
VE - Venezuela 12
BG - Bulgaria 11
PT - Portogallo 11
UZ - Uzbekistan 11
MY - Malesia 10
NO - Norvegia 10
PY - Paraguay 10
CL - Cile 9
DK - Danimarca 9
SK - Slovacchia (Repubblica Slovacca) 9
LB - Libano 8
SA - Arabia Saudita 8
HR - Croazia 7
KE - Kenya 7
DO - Repubblica Dominicana 6
JM - Giamaica 6
PE - Perù 6
TH - Thailandia 6
TN - Tunisia 6
AZ - Azerbaigian 5
BA - Bosnia-Erzegovina 5
GE - Georgia 5
KG - Kirghizistan 5
LV - Lettonia 5
NP - Nepal 5
RS - Serbia 5
ET - Etiopia 4
JO - Giordania 4
MK - Macedonia 4
TT - Trinidad e Tobago 4
UY - Uruguay 4
AL - Albania 3
AM - Armenia 3
BY - Bielorussia 3
CG - Congo 3
EE - Estonia 3
GH - Ghana 3
HN - Honduras 3
LK - Sri Lanka 3
ME - Montenegro 3
PH - Filippine 3
PS - Palestinian Territory 3
SI - Slovenia 3
SN - Senegal 3
TW - Taiwan 3
BB - Barbados 2
BO - Bolivia 2
CR - Costa Rica 2
IS - Islanda 2
LA - Repubblica Popolare Democratica del Laos 2
LY - Libia 2
Totale 14.924
Città #
Singapore 692
Chandler 638
Ashburn 426
Beijing 292
Jacksonville 222
Warsaw 220
Munich 193
Houston 169
Nanjing 150
Dublin 148
Dearborn 142
San Mateo 140
Los Angeles 138
Woodbridge 133
Ann Arbor 132
Fairfield 131
Milan 121
New York 120
Rome 113
Wilmington 113
Hangzhou 103
Nürnberg 95
Redwood City 93
Seattle 93
Jakarta 89
Chicago 82
Helsinki 77
Dallas 72
Bremen 67
Hefei 67
Nanchang 59
Boston 58
Cattolica 52
Lawrence 52
Moscow 52
Frankfurt am Main 48
São Paulo 42
Buffalo 41
The Dalles 39
Hanoi 37
Izmir 37
London 37
Marseille 36
Sydney 36
Hong Kong 35
Brooklyn 34
Cambridge 33
Kunming 33
Ho Chi Minh City 32
Guangzhou 31
Lancaster 29
Shanghai 29
Toronto 27
Boardman 26
Phoenix 26
Portland 26
San Francisco 25
Hyderabad 24
Melbourne 24
Shenyang 24
Abidjan 23
Princeton 23
Santa Clara 23
Tokyo 23
Adelaide 22
Brisbane 22
Brussels 21
Denver 21
Kent 20
Changsha 19
Leawood 19
Atlanta 18
Auburn Hills 18
Hebei 18
Redmond 18
Tianjin 18
Fremont 17
Nuremberg 17
Philadelphia 17
Jiaxing 16
Montreal 16
Poplar 16
Mountain View 15
San Diego 15
University Park 15
Augusta 14
Norwalk 14
San Jose 14
Vienna 14
Wroclaw 14
Zhengzhou 14
Amsterdam 13
Berlin 13
Kansas City 13
Seoul 13
Council Bluffs 12
Istanbul 12
Johannesburg 12
Mexico City 12
Pittsburgh 12
Totale 7.021
Nome #
VITAMIN B12 DEFICIENCY: CORRELATION BETWEEN MTHFR POLYMORPHISMS AND CLINICAL AND LABORATORY FINDINGS 2.882
HIGH-DOSE CHEMOTHERAPY WITH AUTOLOGOUS STEM CELL TRANSPLANTATION IN FIRST LINE TREATMENT FOR HIGH-RISK DIFFUSE LARGE B CELL LYMPHOMA (DLBCL) IN THE RITUXIMAB ERA: AN INTENTION TO TREAT-ANALYSIS 401
Vitamin D deficiency and supplementation in patients with aggressive B-cell lymphomas treated with immunochemotherapy 319
Risk factors for venous thromboembolism in patients with lymphoma requiring hospitalization 314
DNMT1-interacting RNAs block gene-specific DNA methylation 279
PD-L1 expression in peripheral blood granulocytes at diagnosis as prognostic factor in classical Hodgkin lymphoma 261
Quantification of DAPK1 Promoter Methylation in Bone Marrow and Peripheral Blood as a Follicular Lymphoma Biomarker 260
Mutational analysis of bone marrow mesenchymal stromal cells in myeloid malignancies 241
Venous Thromboembolism in Lymphoma: Risk Stratification and Antithrombotic Prophylaxis 216
Interleukin-6 plasma levels are modulated by a polymorphism in the NF-κB1 gene and are associated with outcome following rituximab-combined chemotherapy in diffuse large B-cell non-Hodgkin lymphoma. 215
PTEN/PI3K/AKT PATHWAY DYSREGULATION IN MYELODYSPLASTIC GRANULOCYTES 214
MUTATIONAL ANALYSIS OF BONE MARROW MESENCHIMAL STROMAL CELLS IN MYELOID MALIGNANCIES 208
GSK3β down-regulation in Mesenchymal Stem Cells from patients with Myelodysplastic Syndrome. 208
Anemia in Diffuse Large B cell Non-Hodgkin Lymphoma: The Role of IL-6, Hepcidin and Erythropoietin 200
CD68+ cell count, early evaluation with PET and plasma TARC levels predict response in Hodgkin lymphoma 198
Anemia in Hodgkin's lymphoma: the role of interleukin-6 and hepcidin 197
DEREGULATION OF PI3K/AKT SIGNALING IN BONE MARROW MESENCHIMAL STROMAL CELLS FROM PATIENTS WITH DE NOVO AND THERAPY-RELATED ACUTE MYELOID LEUKEMIA 191
Increased risk of acute myeloid leukaemia due to polymorphisms in detoxification and DNA repair enzymes. 172
Mutations of epigenetic regulators and of the spliceosome machinery in therapy-related myeloid neoplasms and in acute leukemias evolved from chronic myeloproliferative diseases 169
The viral load of Epstein-Barr virus (EBV) DNA in peripheral blood predicts for biological and clinical characteristics in Hodgkin lymphoma 167
Reduced BRCA1 expression due to promoter hypermethylation in therapy-related acute myeloid leukaemia 167
Cell-free circulating DNA in Hodgkin's and non-Hodgkin's lymphomas. 164
Analysis of genome-wide methylation and gene expression induced by 5-aza-2'-deoxycytidine identifies BCL2L10 as a frequent methylation target in acute myeloid leukemia. 162
Impairment of PI3K/AKT and WNT/β-catenin pathways in bone marrow mesenchymal stem cells isolated from patients with myelodysplastic syndromes 162
Response to 5-azacytidine in a patient with relapsed Hodgkin Lymphoma and a therapy-related myelodysplastic syndrome 161
Mutations of epigenetic regulators and of the spliceosome machinery in therapy-related myeloid neoplasms and in acute leukemias evolved from chronic myeloproliferative diseases 161
Clinical significance of interleukin-10 gene polymorphisms and plasma levels in Hodgkin lymphoma 160
Progressive multifocal leukoencephalopathy in patients with follicular lymphoma treated with bendamustine plus rituximab followed by rituximab maintenance 159
Promoter methylation of DAPK1, E-cadherin and thrombospondin-1 in de novo and therapy-related myeloid neoplasms 157
Epigenetic changes in therapy-related MDS/AML 154
Gene expression profiling of myelodysplastic CD34+ hematopoietic stem cells treated in vitro with decitabine 154
Progressive multifocal leukoencephalopathy in patients with follicular lymphoma treated with bendamustine plus rituximab followed by rituximab maintenance 148
Polymorphisms of detoxification and DNA repair enzymes in myelodyplastic syndromes 145
Whole blood EBV-DNA predicts outcome in diffuse large B-cell lymphoma 144
Promoter methylation of DAPK1, E-cadherin and thrombospondin-1 in de novo and therapy-related myeloid neoplasms 143
Clinical significance of interleukin-10 gene polymorphisms and plasma levels in Hodgkin lymphoma. 141
A T cell lymphoblastic lymphoma with mucormycosis as unusual etiology of acute cerebral ischemia 141
Interleukin-6 plasma levels are modulated by a polymorphism in the NF-κB1 gene and are associated with outcome following rituximab-combined chemotherapy in diffuse large B-cell non-Hodgkin lymphoma 140
Cell-free circulating DNA in Hodgkin's and non-Hodgkin's lymphomas 140
Anti CD20-based immunochemotherapy abolishes antibody response to Covid-19 mRNA vaccine in lymphoma patients vaccinated during active first line treatment 140
The neutrophil/lymphocyte ratio ≥3.5 is a prognostic marker in diffuse large B-cell lymphoma: a retrospective analysis from the database of the Italian regional network ‘Rete Ematologica del Lazio per i Linfomi’ (RELLI) 136
Intravascular large-B cell lymphoma: when lymphoma is suspected but routine diagnostic work-up is negative. 134
Gene expression profiling of myelodysplastic CD34+ hematopoietic stem cells treated in vitro with decitabine. 133
DAP-kinase hypermethylation in the bone marrow of patients with follicular lymphoma 133
DAP-kinase hypermethylation in the bone marrow of patients with follicular lymphoma. 133
Glutathione-S-transferase genotypes influence prognosis in follicular non-Hodgkin's Lymphoma. 131
PU.1 and CEBPA expression in acute myeloid leukemia. 129
Invasive fungal infections in chronic lymphoproliferative disorders: a monocentric retrospective study 125
Novel Targets and Advanced Therapies in Diffuse Large B Cell Lymphomas 124
Anemia in diffuse large B-cell non-Hodgkin lymphoma: the role of interleukin-6, hepcidin and erythropoietin. 124
Invasive fungal infections in chronic lymphoproliferative disorders: A monocentric retrospective study 123
In vitro Effect of Eltrombopag Alone and in Combination With Azacitidine on Megakaryopoiesis in Patients With Myelodysplastic Syndrome 122
Mantle cell lymphoma relapsing at the lymphedematous arm 121
Prognostic role of glutathione S-transferase polymorphisms in acute myeloid leukemia. 120
Primary pancreatic lymphoma in a patient with maturity onset diabetes of the young type 3 118
Outcome of therapy-related myeloid neoplasms treated with azacitidine 118
Comorbidity assessment to determine prognosis in older adult patients with classical Hodgkin lymphoma 115
The prognostic impact of monoclonal immune globulin and free light chain secretion in diffuse large B cell lymphoma (DLBCL) 114
Impairment of PI3K/AKT and WNT/β-catenin pathways in bone marrow mesenchymal stem cells isolated from patients with myelodysplastic syndromes 112
Chemoradiotherapy with temozolomide after high-dose methotrexate for primary CNS lymphoma: a multicenter phase I study of a response-adapted strategy 112
Enhancing lymphoma diagnosis on core needle biopsies: Integrating immunohistochemistry with flow cytometry 111
Bax mutations are an infrequent event in indolent lymphomas and in mantle cell lymphoma 111
Glutathione-S-transferase genotypes influence prognosis in follicular non-Hodgkin's Lymphoma 111
Polymorphism in cytokine genes as prognostic markers in Hodgkin's lymphoma 109
Four doses of unpegylated versus one dose of pegylated filgrastim as supportive therapy in R-CHOP-14 for elderly patients with diffuse large B-cell lymphoma 109
Azacitidine in a patient with myelodysplastic syndrome: Impact of switching from a 5-day to the approved 7-day dosing schedule 108
PD-L1 expression in peripheral blood granulocytes at diagnosis as prognostic factor in classical Hodgkin lymphoma 107
Invasive fungal infections in chronic lymphoproliferative disorders: a monocentric retrospective study 106
Aggiornamenti di Diagnostica Molecolare in Ematologia 103
Body mass index is not associated with survival outcomes and immune-related adverse events in patients with Hodgkin lymphoma treated with the immune checkpoint inhibitor nivolumab 103
Negative prognostic value of glutathione s-transferase (gstm1 and gstt1) deletions in adult acute myeloid leukemia. 99
Burkitt lymphoma as fourth neoplasia in a patient affected by cowden syndrome with a novel PTEN germline pathogenic variant 98
Predicting time to treatment in follicular lymphoma on watchful waiting using baseline metabolic tumour burden 97
Severe cmv infection after chemo-immunotherapy with dose- reduced bendamustine and rituximab in a mantle cell lymphoma old patient 97
Frequent downregulation of the transcription factor Foxa2 in lung cancer through epigenetic silencing 80
CAR-T Cell Therapy for Follicular Lymphomas 78
Endoscopic Ultrasound-Guided Fine Needle Biopsy in the Diagnostic Work-Up of Deep-Seated Lymphadenopathies and Spleen Lesions: A Monocentric Experience 74
Secondary Orbital and Intraocular Lymphoma Treated With Immunochemotherapy 70
May we routinely spare hippocampal region in primary central nervous system lymphoma during whole brain radiotherapy? 68
Case of metastatic melanoma in bone marrow smear 67
Absence of structural mutations of the BAK gene in B cell lymphomas 66
Mutations of epigenetic regulators and of the spliceosome machinery in therapy-related myeloid neoplasms and in acute leukemias evolved from chronic myeloproliferative diseases 66
Treatment with Idelalisib in Patients with Relapsed or Refractory Follicular Lymphoma: The Observational Italian Multicenter FolIdela Study 60
In vitro effect of eltrombopag alone and in combination with azacitidine on megakaryopoiesis in patients with myelodysplastic syndrome 58
The Predictive Role of Baseline 18F-FDG PET/CT Radiomics in Follicular Lymphoma on Watchful Waiting: A Preliminary Study 45
Treatment outcomes in elderly patients ≥ 65 years with Large B-Cell Lymphoma (LBCL): a real-world single center experience focusing on potential CD19-CAR-T eligibility in second line 34
Safety and efficacy of SARS-Cov2 neutralizing monoclonal antibodies after stem cell transplant or CAR-T cell infusion 11
Heterogeneous Surface CD79b Expression in Aggressive B-Cell Lymphomas Assessed by Flow Cytometry on Lymph Node Biopsies 7
Totale 15.085
Categoria #
all - tutte 48.077
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 48.077


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021753 0 0 0 0 0 115 124 33 105 88 247 41
2021/2022871 103 80 13 31 65 36 26 133 51 70 122 141
2022/20231.867 259 261 128 319 114 216 95 141 175 39 74 46
2023/20241.669 54 256 71 92 114 193 81 109 81 151 226 241
2024/20252.804 297 204 269 144 224 113 210 149 325 224 357 288
2025/20262.614 646 223 268 489 892 96 0 0 0 0 0 0
Totale 15.085